Ticker Scorecard - MXCT Basics Company: MaxCyte, Inc. Common Stock IPO Date: July 26, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $406.11M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.01% Avg Daily Range (30 D): $0.12 | 2.60% Avg Daily Range (90 D): $0.11 | 2.63% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .45M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 147 Avg Inst. Trade: $2.44M Avg Inst. Trade (30 D): $.65M Avg Inst. Trade (90 D): $1.68M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.31M Avg Closing Trade (30 D): $.74M Avg Closing Trade (90 D): $2.42M Avg Closing Volume: 528.13K     News Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr) Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc May 22, 2024 @ 12:05 PM MaxCyte Signs Strategic Platform License Agreement... Source: MaxCyte, Inc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.34 $-.11 $-.09 Diluted EPS $-.34 $-.11 $-.09 Revenue $ 45.6M $ 8.16M $ 10.43M Gross Profit $ 39.21M $ 6.24M $ 8.94M Net Income / Loss $ -35.74M $ -11.56M $ -9.38M Operating Income / Loss $ -46.39M $ -14.05M $ -11.97M Cost of Revenue $ 6.39M $ 1.93M $ 1.49M Net Cash Flow $ -12.21M $ -.56M $ 15.26M PE Ratio